Illumina

Illumina's tweets typically receive a moderate level of engagement, with an average of 475 likes and 151 retweets per tweet. Their content is well-received by their followers, indicating a strong connection with their audience.

The primary audience includes researchers, healthcare professionals, and industry stakeholders interested in genomics and biotechnology. They are likely looking for updates on new technologies and scientific breakthroughs.

Illumina emphasizes the life-saving potential of genomic testing for early cancer detection. They showcase their latest technological advancements, such as the NovaSeq X series, to highlight innovation. They engage with employees and share behind-the-scenes content to build a more personal connection with their audience.